Conférence du 01.12.2025

par Prof. Chantal Csajka, Dr. Frédéric Gaspar, Dr. Claire Coumau (CHUV)

• Prof. Dr. Chantal Csajka is Professor of Clinical Pharmacy and Director of the Centre de Recherche et Innovation en Sciences Pharmaceutiques Cliniques (CRISP) at Lausanne University Hospital (CHUV).
  She specializes in clinical pharmacokinetics, therapeutic drug monitoring, pharmacogenetics, drug safety, and personalized medication management. Through her work, she aims to improve medication safety, reduce avoidable harm, and support evidence-based, personalized pharmacotherapy in hospital and outpatient care settings. 
  She leads several initiatives among which SwissMADE, which aims to monitor adverse drug events.
  
  
• Frédéric Gaspar, PhD, is Project Lead at the Centre de Recherche et Innovation en Sciences Pharmaceutiques Cliniques (CRISP) at Lausanne University Hospital (CHUV), where he specializes in the detection and monitoring of adverse drug events (ADEs) in hospital settings.
  He leads projects that leverage advanced modelling and data-driven methods — including data mining and electronic medical record-based surveillance — to improve medication safety and support safer prescribing practices in inpatient care.
  
  
• Claire Coumau, PhD, is Postdoctoral Researcher at the Centre de Recherche et Innovation en Sciences Pharmaceutiques Cliniques (CRISP) at Lausanne University Hospital (CHUV), working at the intersection of clinical pharmacy, pharmacovigilance, and patient safety.
  Her research focuses particularly on the detection and prevention of adverse drug events (ADEs) in hospitalized patients and contributes to developing automated tools for ADE detection to improve drug safety in older inpatients and support safer prescribing practices.